Marcin Stanczak
Overview
Explore the profile of Marcin Stanczak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pastorczak A, Urbanska Z, Styka B, Miarka-Walczyk K, Sedek L, Wypyszczak K, et al.
Leukemia
. 2024 Aug;
38(11):2344-2354.
PMID: 39192035
Chromothripsis (cth) is a form of genomic instability leading to massive de novo structural chromosome rearrangements in a one-time catastrophic event. It can cause cancer-promoting alterations, such as loss of...
2.
Stanczak M, Wyszomirski A, Slonimska P, Kolodziej B, Jablonski B, Stanislawska-Sachadyn A, et al.
Front Neurol
. 2024 Jun;
15:1399345.
PMID: 38938784
Background: Hemorrhagic transformation (HT) in acute ischemic stroke is likely to occur in patients treated with intravenous thrombolysis (IVT) and may lead to neurological deterioration and symptomatic intracranial hemorrhage (sICH)....
3.
Smyczynska U, Stanczak M, Kuljanin M, Wlodarczyk A, Stoczynska-Fidelus E, Taha J, et al.
Genes (Basel)
. 2022 Dec;
13(12).
PMID: 36553637
Alström syndrome (ALMS) and Bardet-Biedl syndrome (BBS) are rare genetic diseases with a number of common clinical features ranging from early-childhood obesity and retinal degeneration. ALMS and BBS belong to...
4.
Cypryk W, Czernek L, Horodecka K, Chrzanowski J, Stanczak M, Nurmi K, et al.
J Immunol
. 2022 Dec;
210(3):322-334.
PMID: 36525001
Human macrophages secrete extracellular vesicles (EVs) loaded with numerous immunoregulatory proteins. Vesicle-mediated protein secretion in macrophages is regulated by poorly characterized mechanisms; however, it is now known that inflammatory conditions...
5.
Zmyslowska A, Smyczynska U, Stanczak M, Jeziorny K, Szadkowska A, Fendler W, et al.
Front Endocrinol (Lausanne)
. 2022 Dec;
13:1057056.
PMID: 36506055
Background: Patients with the rare syndromic forms of monogenic diabetes: Alström syndrome (ALMS) and Bardet-Biedl syndrome (BBS) have multiple metabolic abnormalities, including early-onset obesity, insulin resistance, lipid disorders and type...
6.
Urbanska Z, Lejman M, Taha J, Madzio J, Ostrowska K, Miarka-Walczyk K, et al.
Neoplasia
. 2022 Oct;
35:100840.
PMID: 36288679
We analyzed the pattern of whole-genome copy number alterations (CNAs) and their association with the kinetics of blast clearance during the induction treatment among 195 pediatric patients with B-cell precursor...
7.
Zmyslowska A, Kuljanin M, Malachowska B, Stanczak M, Michalek D, Wlodarczyk A, et al.
Cell Commun Signal
. 2021 Nov;
19(1):116.
PMID: 34801048
Background: Wolfram syndrome (WFS) is a rare autosomal recessive syndrome in which diabetes mellitus and neurodegenerative disorders occur as a result of Wolframin deficiency and increased ER stress. In addition,...
8.
Zmyslowska A, Stanczak M, Nowicka Z, Waszczykowska A, Baranska D, Fendler W, et al.
BMJ Open Diabetes Res Care
. 2020 Nov;
8(2).
PMID: 33132210
Introduction: Patients with the ultra-rare Wolfram syndrome (WFS) develop insulin-dependent diabetes and progressive neurodegeneration. The aim of the study was to quantify microRNAs (miRNAs) in sera from patients with WFS,...
9.
Zielinska M, Kulikowska D, Stanczak M
Waste Manag
. 2020 Jul;
114:174-182.
PMID: 32679475
The aim of this study was to investigate the efficiency of removal of difficult-to-biodegrade organic compounds from real stabilized landfill leachate with a membrane process alone and in combination with...
10.
Santana-Codina N, Chandhoke A, Yu Q, Malachowska B, Kuljanin M, Gikandi A, et al.
Cell Rep
. 2020 Apr;
30(13):4584-4599.e4.
PMID: 32234489
Covalent inhibitors of the KRAS oncoprotein have recently been developed and are being evaluated in clinical trials. Resistance to targeted therapies is common and may limit long-term efficacy of KRAS...